SLNO

Soleno Therapeutics, Inc.

Healthcare›Biotechnology|NASDAQ Capital Market|US

Price

$39.49

Market Cap

$2.12B

Beta

-2.81

P/E

231.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)+105.32%

Revenue CAGR 3Y+0.00%

P/E Ratio231.2

PEG Ratio1.65

FCF Yield+2.21%

Debt / Equity0.01

Interest Coverage1.9x

No credit card required

Already have an account? Sign in to view the full analysis for SLNO.